- Home
- LRHC vs PPCB Comparison
LRHC vs PPCB Comparison
Compare LRHC & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | LRHC | PPCB |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | Australia |
| Employees | N/A | 2 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6M | 1.6M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | LRHC | PPCB |
|---|---|---|
| Price | $0.58 | $0.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 791.9K | ★ 1.4M |
| Earning Date | 04-17-2026 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,448,786.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 118.67 | N/A |
| 52 Week Low | $0.08 | $0.10 |
| 52 Week High | $11.21 | $10.69 |
Technical Indicators
Market Signals| Indicator | LRHC | PPCB |
|---|---|---|
| Relative Strength Index (RSI) | 37.16 | 30.92 |
| Support Level | $0.36 | N/A |
| Resistance Level | $0.75 | $0.40 |
| Average True Range (ATR) | 0.09 | 0.01 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 11.16 | 23.74 |
Price Performance
Historical ComparisonAbout LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
About PPCB Propanc Biopharma Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.